Harvard’s Wyss Institute joins forces with Cytosurge to improve CRISPR-based multiplexed gene editing

May 04 2020

Collaboration focuses on developing multiplexed gene editing approaches using single-cell nano-manipulation technology that maintains cell viability and fitness.